Healthcare Stocks
Latest news, explainers and analysis on Healthcare Stocks. Tracking 13 stories on Arth Vani.
Connected in the graph
Latest on Healthcare Stocks
US Stocks Rise Tuesday: Healthcare Boosts Dow, Tech Takes a Breather
Wall Street concluded Tuesday's trading session higher, primarily driven by a shift towards healthcare and other value stocks. The Dow Jones Industrial Average and the S&P 500 both posted gains, while the technology-heavy Nasdaq Composite experienced a slight decline as tech shares paused after their recent rebound.
IPOBreakingMolbio Diagnostics Surges 83% Since Listing: Motilal Oswal Issues 'Buy' Rating
Molbio Diagnostics has delivered massive returns of over 80% within two months of its stock market debut. Brokerage firm Motilal Oswal remains bullish on the stock, citing strong growth potential despite the recent price rally.
Nutex Health Secures Approval for Dual Listing on Nasdaq Texas Exchange
US-based healthcare services firm Nutex Health Inc. announced on September 22, 2026, it has received approval to dual-list its common stock on Nasdaq Texas. The physician-led company, which operates 28 facilities, already trades on Nasdaq under the ticker NUTX.
Yatharth Hospitals Stock Surges 10% to Record High on Advent's Stake Deal
Yatharth Hospitals shares hit a fresh record high, climbing 10% after news that private equity firm Advent International is set to acquire a 25% stake. The stock has now risen 20% recently, indicating strong investor interest following the potential deal.
Danaher vs. Medtronic: Analysis of Global Healthcare Recovery Potential
Due to the absence of source content, a detailed summary comparing Danaher and Medtronic's recovery potential cannot be provided. This report would typically analyze their financial health, market position, and growth drivers to offer investment insights.
Thermo Fisher vs. Intuitive Surgical: A Global Healthcare Stock Valuation Debate
This report is unable to provide a summary as the detailed content comparing Thermo Fisher Scientific and Intuitive Surgical's valuations was not provided in the source material. We cannot analyze which premium healthcare stock deserves its current valuation without the underlying financial data and analysis.
Medtronic, Thermo Fisher: Global Healthcare Stock Outlook for Investors
This report would typically compare healthcare giants Medtronic and Thermo Fisher, analyzing their turnaround strategies and identifying potential investment upsides. However, the original article content was not provided, preventing a factual deep dive.
J&J's $5.5 Billion Talc Settlement: A Clear Path or Lingering Legal Cloud?
Johnson & Johnson (J&J) has proposed a $5.5 billion (approximately ₹45,800 crore) settlement to resolve a significant portion of lawsuits alleging its talc products caused cancer. This move prompts investors to question whether the substantial offer signals an end to the company's prolonged legal challenges or if significant risks still loom.
IPOBreakingMolbio Diagnostics Raises ₹281 Crore From Anchor Investors Ahead of IPO Launch
Goa-based Molbio Diagnostics has secured ₹281.5 crore from institutional anchor investors as it prepares for its public market debut. The company plans to raise up to ₹940 crore to fund manufacturing expansion and infrastructure upgrades.
IPOBreakingManipal Health Shares List at 11% Premium: Investors Book Gains on Market Debut
Manipal Health made a positive debut on the stock exchanges today, listing at a premium of over 11% against its issue price. The shares opened at ₹652 on the NSE and ₹655 on the BSE, rewarding successful allottees with immediate listing gains.
Global Hedge Fund D.E. Shaw Backs Boston Scientific as Top Healthcare Stock Pick
Global investment giant D.E. Shaw has identified Boston Scientific Corporation (BSX) as a high-potential stock for investors. The move highlights growing institutional confidence in medical technology firms as healthcare spending rises globally.
Global Healthcare Dividends: Why Pfizer Misses the Cut for Top Income Stocks
While healthcare stocks are often seen as safe havens for dividend seekers, recent market shifts have changed the outlook for major players. Experts are highlighting two specific healthcare stocks for their consistent payouts, while cautioning that former favorite Pfizer may no longer be the best choice for income-focused investors.
Shift From Broad Market Bets to Banking and Healthcare as Volatility Rises
With geopolitical tensions in West Asia impacting market stability, experts suggest moving away from broad index tracking. Investors are advised to focus on specific sectors like banking, healthcare, and industrials which show strong earnings potential for the coming years.
Some listings may be sponsored and Arth Vani may earn a referral fee. All information is for educational purposes only — verify terms and suitability with the provider before acting. Not financial advice.